Literature DB >> 28959129

Shiitake Dermatitis-like Eruption Due to Tegafur/Gimeracil/Oteracil Combination Usage

Hiroyuki Goto1, Kazunari Sugita1, Shigeto Yanagihara1, Osamu Yamamoto1.   

Abstract

S-1 is a combination drug of tegafur, gimeracil and oteracil potassium that is designed on the basis of 5- fluorouracil. We report here for the first time that S-1 is a causative agent of drug eruption mimicking shiitake dermatitis. A 58-year-old Japanese man presented with pruritic erythemas arranged in a linear fashion. He had been treated with S-1 for esophageal cancer. Although differential diagnosis included shiitake dermatitis and dermatomyositis, he had not eaten raw shiitake mushroom, and he did not have other cutaneous lesion such as Gottron's sign and abnormalities of peripheral blood examination including Jo-1 antibody and antinuclear antibody. Histopathological examination revealed necrotic keratinocytes in the Malpighian layer, vacuolar change in the basal layer, and lymphocytic and eosinophilic infiltration in the upper dermis. Based on clinical and histological findings, we made a diagnosis of drug eruption due to S-1.

Entities:  

Keywords:  S-1; dermatomyositis; drug eruption; linear erythema; shiitake dermatitis

Year:  2017        PMID: 28959129      PMCID: PMC5611473     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  8 in total

1.  Bleomycin induced flagellate erythema: Revisiting a unique complication.

Authors:  Ahitagni Biswas; Pritee B Chaudhari; Punit Sharma; Lavleen Singh; Pramod Kumar Julka; Gomathy Sethuraman
Journal:  J Cancer Res Ther       Date:  2013 Jul-Sep       Impact factor: 1.805

2.  Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.

Authors:  Atsuko Adachi; Hiroshi Nagai; Tatsuya Horikawa
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

Review 3.  Shiitake dermatitis: a report of 3 cases and review of the literature.

Authors:  Emily Y Chu; Dipti Anand; Aerlyn Dawn; Rosalie Elenitsas; Donald J Adler
Journal:  Cutis       Date:  2013-06

4.  Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer.

Authors:  Hideki Ueno; Takuji Okusaka; Junji Furuse; Kenji Yamao; Akihiro Funakoshi; Narikazu Boku; Shinichi Ohkawa; Osamu Yokosuka; Katsuaki Tanaka; Fuminori Moriyasu; Shoji Nakamori; Tosiya Sato
Journal:  Jpn J Clin Oncol       Date:  2011-06-29       Impact factor: 3.019

5.  Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients.

Authors:  Takeharu Yamanaka; Shigemi Matsumoto; Satoshi Teramukai; Ryota Ishiwata; Yoji Nagai; Masanori Fukushima
Journal:  Cancer Chemother Pharmacol       Date:  2007-10-09       Impact factor: 3.333

6.  Histopathology of Gottron's papules--utility in diagnosing dermatomyositis.

Authors:  Gary Mendese; Meera Mahalingam
Journal:  J Cutan Pathol       Date:  2007-10       Impact factor: 1.587

7.  Changes in Standard Treatments and Postoperative Outcomes for Advanced Gastric Cancer at One Institute over an 11-Year Period.

Authors:  Abdul Kader; Kozo Miyatani; Seigo Takaya; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Hiroaki Saito; Shinji Otani; Toshiro Wakatsuki; Masahide Ikeguchi
Journal:  Yonago Acta Med       Date:  2015-08-18       Impact factor: 1.641

8.  Shiitake dermatitis.

Authors:  Camila Nemoto de Mendonça; Priscila Mara Chaves E Silva; João Carlos Regazzi Avelleira; Fátima Satomi Nishimori; Flavia de Freire Cassia
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.